4 Results for "

BLU667

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "BLU667" in MCE Product Catalog:

17
17 Cited Publications
Cat. No.: HY-112301
CAS No.: 2097132-94-8
Purity:  99.98%
Synonyms: BLU-667
Target:  

RET

Research Areas:  

Cancer

Pralsetinib (BLU-667) is a highly potent, selective RET inhibitor. Pralsetinib (BLU-667) inhibits WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion with IC50s of 0.4, 0.3, 0.4, 0.4, and 0.4 nM, respectively .
loading...
    loading...
Cat. No.: HY-112301A
CAS No.: 2097132-93-7
Purity:  96.07%
Synonyms: trans-BLU-667
Target:  

RET

Research Areas:  

Cancer

trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129 .
loading...
    loading...
Cat. No.: HY-112301R
CAS No.: 2097132-94-8
Synonyms: BLU-667 (Standard)
Target:  

Reference Standards RET

Research Areas:  

Cancer

Pralsetinib (Standard) is the analytical standard of Pralsetinib. This product is intended for research and analytical applications. Pralsetinib (BLU-667) is a highly potent, selective RET inhibitor. Pralsetinib (BLU-667) inhibits WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion with IC50s of 0.4, 0.3, 0.4, 0.4, and 0.4 nM, respectively .
loading...
    loading...
Cat. No.: HY-112301AR
CAS No.: 2097132-93-7
Synonyms: trans-BLU-667 (Standard)
Target:  

RET Reference Standards

Research Areas:  

Cancer

trans-Pralsetinib (Standard) is the analytical standard of trans-Pralsetinib. This product is intended for research and analytical applications. trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129 .
loading...
    loading...